Introduction
Normal proliferating cells are able to respond to growth factor signals during the early G1 phase of the cell cycle. However, late in G1, once they have progressed through the restriction point (R), they become refractory to mitogenic signals and are committed to enter into the S phase. Progression through the G1 phase is regulated by the sequential catalytic activation of the cyclin D-CDK6/4 and cyclin E-CDK2 complexes. The catalytic activity of these complexes is regulated by the degree of phosphorylation of CDK and by the amount of CDK inhibitors (CKIs) bound to the complex (Zetterberg et al., 1995) . Two structurally and functionally related CKIs, p21
Waf1 (EI Deiry et al., 1993; Harper et al., 1993) and p27 Kip1 Toyoshima and Hunter, 1994) , are regulated by mitogenic signals. The expression of p21 Waf1 is regulated through p53-dependent and -independent pathways and its upregulation is usually associated with G1 arrest (EI Deiry et al., 1993; Harper et al., 1993; Macleod et al., 1995) . However, p21
Waf1 has also been associated with cell-cycle progression (La Baer et al., 1997; Macleod et al., 1995; Zhang et al., 1994) and is induced by the mitogen-activated protein kinase signaling (MAPK) pathway (Liu et al., 1996) .
High amounts of p27 Kip1 suppress cell proliferation, and its role in regulating the R point has been demonstrated (Coats et al., 1996) . In hematopoietic cells, a stoichiometric interplay between the relative amounts of p21 Waf1 and p27 Kip1 appears to regulate cellcycle progression. In fact, IL-2 stimulation of human PBMCs or treatment of the myeloid cell line MO7e with Steel factor (SLF) and granulocyte-macrophage colony stimulating factor (GM-CSF) determines the upregulation of p21
Waf1 and downregulation of p27 Kip1 . Accordingly, when cells are deprived of growth factors, an inverse relationship in the relative amounts of these two CKIs has been observed Mantel et al., 1996; Nourse et al., 1994) . Upon IL-2 triggering of normal human PBMCs, the relative stoichiometry of p21 Waf1 and p27 Kip1 is inverted, determining the activation of the cyclin E-CDK2 complex, which, in turn, allows passage through the R point and entry into the S phase Nourse et al., 1994) .
HTLV-I infection disrupts the physiological mechanisms of T-cell growth regulation (Markham et al., 1983; Miyoshi et al., 1981; Popovic et al., 1983; Franchini, 1995) . While in the early phase of transformation HTLV-I-infected T-cells require IL-2 to proliferate, in the late phase of HTLV-I transformation, T-cells appear to lose the R point control as indicated by their continuous proliferative state even in the absence of IL-2. In fact, a constitutive activation of the IL-2R pathway has been demonstrated in vivo (Takemoto et al., 1997) and in vitro (Migone et al., 1995 Xu et al., 1995) .
Since p21 Waf1 and p27 Kip1 appear to be the downstream eectors of growth-signal pathways, their involvement in HTLV-I transformation has been analysed. Our study shows that in the early phase of HTLV-I transformation (IL-2 dependent), the R point does not appear to be aected, but in the late phase (IL-2 independent), the deregulation of both p21 Waf1 and p27
Kip1 correlate with loss of cellular response to antiproliferative signals. In addition, our results demonstrate that low levels of p27
Kip1 aect the cyclin E-CDK2 inhibitory threshold, determining the constitutive activation of this complex in the late phase of HTLV-I transformation.
Results

p27
Kip1 expression in HTLV-I-infected T-cell lines
Low levels of p27 Kip1 have been correlated with cell transformation (Johnson et al., 1998) . The level of p27
Kip1 mRNA and protein expression was analysed in ten HTLV-I-infected T-cell lines, four IL-2 dependent (N1186, N1185, LAF, E55) and six IL-2 independent (C91/PL, MJ. C10/MJ, MT2, C8166, N1186-94) as well as in normal PHA-PBMCs.
No signi®cant dierence in the amount of p27 Thus, the maintenance of a low steady state level of p27 Kip1 in HTLV-I-transformed (IL-2 independent) cells appears to be regulated at a post-transcriptional level, consistent with the notion that p27
Kip1 cellular level is regulated by phosphorylation and ubiquitination (Pagano et al., 1995; Shea et al., 1997; Vlach et al., 1997) .
In contrast, p21
Waf1 was consistently found highly expressed in HTLV-I-infected T-cells regardless of their requirement for IL-2 and presumably the viral transactivator Tax contributes to maintain high level of p21 mRNA (Akagi et al., 1996; Cereseto et al., 1996) .
Cell-cycle regulation in early and late phases of HTLV-I infection
To further extend the analysis of p21
Waf1 and p27 Kip1 in HTLV-I transformation their levels of expression have been analysed in two sibling HTLV-I-infected T-cell lines, N1186 (IL-2 dependent) and N1186-94 (IL-2 independent), following growth-factor depletion or rapamycin treatment, and compared to similarly treated PHA-PBMCs.
In the case of PHA-PBMCs, deprivation of serum and IL-2 for 72 h induces downregulation of p21 Waf1 and p27 Kip1 were respectively upregulated and downregulated, returning to the baseline level of expression within 48 h (Figure 2 , lane 3). In contrast, the presence of rapamycin in culture media partially prevented the reconstitution of the baseline expression of the two CKIs (Figure 2 , lane 4). Likewise, in N1186 cells after 72 h of serum/IL-2 deprivation, p21
Waf1 was downregulated while p27
Kip1 was upregulated. Both p21
Waf1 and p27 Kip1 returned to the baseline level of expression within 48 h following addition of standard serum/IL-2 to starving culture media, whereas the levels of p21
Waf1 and p27 Kip1 minimally changed in the presence of rapamycin (Figure 2 , lanes 5 ± 8).
In contrast, in the sibling IL-2-independent T-cell line (N1186-94), the relative amounts of the two CKIs were not aected by serum withdrawal or by rapamycin treatment (Figure 2 , lanes 9 ± 12), indicating their lack of responsiveness to both antiproliferative signals. corresponded to alterations in cell-cycle progression. The ratio between the percentage of cells in G1 and S phases was measured following propidium iodide (PI) staining of cells subjected to growth-factor deprivation or rapamycin treatment.
Serum-and IL-2-deprived PHA-PBMCs arrested in G1 as demonstrated by the eightfold increase in the G1/S ratio when compared with exponentially growing cells (Figure 3 , columns 1 and 2). Following starvation, cells cultured in serum/IL-2 progressed to the S phase within 48 h unless rapamycin was added (Figure 3 , columns 3 and 4). Therefore, G1 cell-cycle arrest in PHA-PBMCs paralleled decreased expression of p21 Waf1 and simultaneous increase of p27 Kip1 observed in Figure  2 . Similarly, in N1186 cells, the reduction of p21 Decreased ability of N1186 cells to arrest in G1 following rapamycin treatment correlates in particular with a less evident induction of p27
Kip1 rather than downregulation of p21
Waf1
, consistent with the notion that rapamycin induced G1 cell-cycle arrest is mediated by p27
Kip1 (Dumont et al., 1995) . In the case of the sibling IL-2-independent T-cell line N1186-94, neither serum withdrawal nor rapamycin induced signi®cant G1 arrest (Figure 3 , columns 9 ± 12), in agreement with Figure 2 (lanes 9 ± 12) in which regulation of both p21
Waf1 and p27 Kip1 following these antiproliferative signals was not observed. Thus, HTLV-I-immortalized T-cells (early phase) respond to serum/IL-2 starvation in a manner similar to PHAPBMCs but appear to be less responsive to rapamycin. On the other hand, fully transformed T-cells (late phase) become refractory to both G1 arrest signals and this unresponsiveness appears to be correlated with the lack of regulation of the total cellular amounts of both p21
Waf1 and p27
Kip1
.
Antiproliferative signals do not modulate cyclin E-CDK2 activity in HTLV-I-transformed T-cells
In the absence of proper growth conditions, cyclin E-CDK2 catalytic activity decreases and cells arrest in G1. The addition of growth factors restores the catalytic activity associated with cyclin E, and the cells advance past the R point and enter into the S phase of the cell cycle (Zetterberg et al., 1995) . To assess the catalytic activity associated with cyclin E, kinase assays were performed on extracts from PHAPBMCs, N1186, and N1186-94 cells exposed to antiproliferative signals. In PHA-PBMCs and N1186 cells, but not in N1186-94 cells, cyclin E-associated kinase activity decreased following serum/IL-2 starvation ( Figure 4A , lanes 1, 2, 5, 6, 9, and 10). This ®nding was con®rmed and extended by studying the kinetics of induction of cyclin Eassociated kinase activity following the addition of standard culture conditions to starved PHA-PBMCs, N1186, and N1186-94 cells. As shown in Figure 4B , steady-state levels of kinase activity were restored as early as 8 h after the addition of serum and IL-2 in both PHA-PBMCs and N1186 cells, while no signi®cant changes were observed in N1186-94 cells.
The addition of serum/IL-2 to starved PHA-PBMCs in presence of rapamycin partially impaired the restoration of the kinase activity to the levels observed in cells grown in absence of the drug ( Figure 4A , compare lane 3 to lane 4). However, in both the N-1186 and N1186-94 cells, the level of cyclin Eassociated kinase activity was not signi®cantly modulated by rapamycin treatment (Figure 4A, lanes 7, 8 and 11, 12) , consistent with the decreased sensitivity of HTLV-I-infected cells to rapamycin treatment shown in Figures 2 and 3 .
Regulation of the cyclin E-CDK2 catalytic activity occurs at least through two mechanisms: activation of CDK2 activity by phosphorylation at position Thr-160 (Gu et al., 1992; Morgan, 1995) and modulation of the stoichiometry of p21
Waf1 and p27 Kip1 bound to the complex (La Baer et al., 1997; Zhang et al., 1994) . To dissect which of these regulatory mechanisms could be hampered in N1186-94 cells, we analysed both the phosphorylation status of CDK2 and the amount of inhibitors bound to cyclin E.
The active phosphorylated form of CDK2 bound to cyclin E was detected by immunoprecipitation of cyclin E from cell extracts of exponentially growing PHAPBMCs and N1186 and N1186-94 cells ( Figure 4C , panel a). Seventy-two hours following serum and IL-2 deprivation, the slower migrating form corresponding to the underphosphorylated/inactive CDK2 (Gu et al., Figure 3 Eect of IL-2/serum deprivation and rapamycin treatment on cell-cycle progression of PHA-PBMC, N1186, and N1186-94 cells. Cell-cycle analysis following propidium iodide staining of PHA-PBMCs, N1186, and N1186-94 cells before (columns 1, 5 and 9) and after 72 h of culture in basal medium without serum/IL-2 (PHA-PBMCs and N1186 ± columns 2 and 6) or serum (N1186-94 ± column 10). Following serum starvation, cells were cultured for 48 h in standard serum/IL-2 conditions with (columns 4, 8, and 12) or without (columns 3, 7 and 11) 60 nM rapamycin. The results are shown as the mean values of the percentage of cells in G1 relative to the percentage in S phase, obtained from ®ve independent experiments. The standard deviation is indicated by the vertical bars 1992; Ko et al., 1992 Ko et al., , 1993 was increased in PHAPBMCs, N1186, and N1186-94 cells. However, the increase of underphosphorylated/inactive CDK2 paralleled an increase of p27
Kip1 bound to cyclin E in PHAPBMCs and N1186 but not in N1186-94 ( Figure 4C , panel c), suggesting a dissociation between CDK2 dephosphorylation and p27
Kip1 induction in N1186-94 cells.
Analysis of the p21 Waf1 content in the cyclin E complex revealed undetectable p21
Waf1 in PHA-PBMCs and high amounts in both N1186 and N1186-94 cells ( Figure 4C, panel b) . Starvation conditions did not change the expression of cyclin E in either PHAPBMCs or in both HTLV-I-infected T-cell lines ( Figure 4C, panel d) .
To determine whether this phenomenon is a general event in HTLV-I transformation, we analysed the cellcycle response and the cyclin E-complex regulation in two other IL-2-dependent (N1185, LAF) and three IL-2-independent transformed HTLV-I infected T-cell lines (C8166, MJ, MT-2). Following 72 h of serum/ IL-2 deprivation, cyclin E-associated kinase activity was downregulated in the N1185 and LAF cell lines (Figure 5a ). The downregulation of the kinase activity corresponded to an arrest of the N1185 cells in G1, as indicated by the increased G1/S ratio presented at the Figure 4 Relative amount of CKI assembled in the cyclin E-CDK complex and its activity in the sibling cell lines N1186 and N1186-94. (A) Cyclin E was immunoprecipitated and kinase activity on histone H1 was tested as described in Materials and methods. Lysates derived from PHA-PBMCs, N1186, and N1186-94 cells before (A, lanes 1, 5, and 9) and after 72 h of serum/IL-2 deprivation (PHA-PBMCs and N1186 ± lanes 2, 6) or serum deprivation (N1186-94 ± lane 10). Following serum starvation, cells were grown for 48 h in standard serum/IL-2 conditions with (lanes 4, 8, 12) or without (lanes 3, 7, and 11) 60 nM rapamycin. The ®gure shows representative results obtained from one out of three independent experiments. (B) Cyclin E-associated kinase activity analysed in PHA-PBMCs, N1186, and N1186-94 cells before (Exp), after starvation (0 h), and at 8 and 24 h after the addition of serum/IL-2 to previously starved cells. (C) Immunoprecipitation of cyclin E and Western blot analysis of CDK2 (a), p21
Waf1 (b), and p27
Kip1 (c) in PHA-PBMCs, N1186, and N1186-94 cells before (+) and after (7) serum and IL-2 deprivation in the case of PHA-PBMCs and N1186 cells, or serum deprivation only, in the case of the N1186-94 cells. The same lysates were analysed for total cyclin E by Western blot (d). CDK2* indicates the inactive CDK2 (underphosphorylated) form. Similar results were obtained in four independent experiments Limiting amounts of p27 Kip1 in HTLV-I transformation A Cereseto et al bottom of the ®gure, and to an increase in cell death by apoptosis in LAF cells, as indicated by sub-G1 peak detected following serum/IL-2 deprivation (data not shown). In contrast, the cyclin E-associated kinase activity remained virtually unchanged in transformed C8166, MJ, and MT-2 cell lines cultured for the same period of time in low serum condition (Figure 5b ). Accordingly, following serum deprivation, these cells did not arrest in G1 (see G1/S ratio shown in the lower part of Figure 5b ). Thus, as observed in the sibling N1186 and N1186-94, the lack of G1 arrest of HTLV-I-transformed T-cells following metabolic deprivation appeared to correlate with a lack of cyclin E/CDK inactivation.
To analyse the regulation of the cyclin E/CDK2 complex, the lysates from all cell lines were immunoprecipitated with antibodies to cyclin E and the immunoprecipitates were immunoblotted for CDK2 and p27
Kip1
. In the N1185 cells, an increase of underphosphorylated/inactive CDK2 and p27 Kip1 bound to cyclin E as well as an increase of total p27
Kip1 was observed following serum/IL-2 deprivation ( Figure 5c , lanes 2 and 12, and e, lane 22). In the same conditions, in LAF cells, while the amount of free as well as cyclin E-bound p27
Kip1 signi®cantly increased (Figure 5c , lane 14, and e, lane 24), the underphosphorylated/inactive form of CDK2 remained unchanged (Figure 5c, lane 4) . The lack of induction of the underphosphorylated/inactive CDK2 within the complex in LAF cells may correlate with the occurrence of apoptosis rather than G1 arrest observed in these cells.
In contrast, in the HTLV-I-transformed cell lines C8166, MJ, and MT-2, the free and cyclin E-bound amount of p27 Kip1 did not substantially increase following serum deprivation, although an increase in the underphosphorylated/inactive CDK2 was observed (Figure 5d and f) as observed in the N1186-94 cells (Figure 4) .
Altogether, these observations suggest that insufficient levels of p27 Kip1 bound to the cyclin E-CDK2 complex may explain the constitutive activation of this 
Kip1 is limiting in HTLV-I-transformed T-cells
Exposure of HTLV-I-infected cells to metabolic stress or rapamycin suggested that insucient amounts of p27 Kip1 were responsible for the lack of G1 arrest observed.
To demonstrate directly this hypothesis, reconstitution experiments were performed using cell lysates from PHA-PBMCs and the IL-2-independent N1186-94 cells. In PHA-PBMCs arrested in G1 by serum/IL-2 withdrawal, the cyclin E-associated kinase activity was reduced by 80% (Figure 6a , columns 1 and 2). Lysates derived from the G1-arrested PHA-PBMCs were added to the lysates from proliferating PHA-PBMCs and cyclin E-kinase assays were performed. As expected (Nourse et al., 1994) , the inhibiting factors present in G1-arrested cell extracts lowered the kinase activity detected in extracts from proliferating cells by 50% (Figure 6a, column 3) . Similarly, the addition of G1-arrested PHA-PBMCs extracts, high in p27 Kip1 , to the extracts from N1186-94 serum-deprived cells also lowered the kinase activity detected in N1186-94 cell extracts alone (50% decrease) (Figure 6b , columns 1 and 2), suggesting that the amount of p27
Kip1 in the N1186-94 extract is limiting. As expected, kinase inhibition in extracts from N1186-94 cells was not observed when lysates derived from exponentially growing PHA-PBMCs, low in p27 Kip1 , were added ( Figure 6b , compare columns 2 and 6).
Since p27 Kip1 is heat stable, the same experiments were performed after boiling the lysate from G1-arrested PHA-PBMCs before its addition to the N1186-94 serum-starved extracts; no substantial changes of the inhibitory eect of the G1-arrested PHA-PBMCs lysate was observed (Figure 6b , compare columns 2 and 3), further suggesting that this eect could be mediated by p27 Kip1 . To further con®rm that the heat-stable p27
Kip1 contained in the G1-arrested PHA-PBMCs extracts was responsible in inducing inhibition of cyclin E-associated kinase activity of the N1186-94 extracts, the latter was mixed with p27 Kip1 -depleted G1-arrested PHA-PBMC extracts. As demonstrated in column 4 of Figure 6b , G1-arrested PHA-PBMC lysate, depleted in p27
Kip1 , failed to decrease the cyclin E-associated kinase activity in the N1186-94 extracts whereas control antibody had no eect ( Figure  6b , compare columns 2, 4 and 5).
Altogether, these results demonstrate that, in presence of adequate amounts of p27 Kip1 , the catalytic activity of the cyclin E complex in N1186-94 starved cells can be downregulated and that insucient amounts of p27 Kip1 may be responsible for the . (a) Cyclin E immunoprecipitates from PHA-PBMCs were assayed for histone H1-kinase activity before (column 1) and after 72 h of serum/IL-2 depletion (column 2). In column 3, the lysate used in column 2 was incubated with the lysate used in column 1, as described in Materials and methods, before testing for the histone H1-kinase activity. (b) Cyclin E immunoprecipitates from serum-deprived N1186-94 cells were assayed for histone H1-kinase activity before (column 1) and after addition of lysates from PHA-PBMCs serum/IL-2 starved (column 2), serum/IL-2 starved and heated at 1008C for 5 min (column 3), serum/IL-2 deprived and incubated with p27
Kip1 antibodies (column 4), serum/IL-2 starved and incubated with control serum (column 5), and with lysates from exponentially growing PHA-PBMCs (column 6). The results shown are the mean values obtained from three independent experiments and are plotted relative to the amount of kinase activity of exponentially growing PHA-PBMCs in A or starved N1186-94 cells in B. Vertical bars represent standard deviations. In the experiments where one lysate has been added to another, in order to obtain the eective kinase modulation of the sample analysed, the activity of the lysate added has been subtracted deregulated cell growth observed in the late phase of HTLV-I transformation.
P13K inhibition is associated with upregulation of p27
Kip1 and cell cycle arrest in HTLV-I-immortalized and -transformed T-cells
A recent report suggests that the regulation of p27 Kip1 expression by IL-2 occurs through the activity of P13K (Brennan et al., 1997) . To investigate whether the decreased amount of p27
Kip1 observed in HTLV-Itransformed T-cells results from the constitutive activation of P13K, three IL-2-dependent and four IL-2-independent HTLV-I-infected T-cell lines and PHA-PBMC were treated with the speci®c inhibitor of P13K, LY294002, and analysed 24 h later for p27 Kip1 expression and DNA content. Drug treatment induced G1 arrest in PHA-PBMC as well as in HTLV-Iinfected T-cell lines regardless of their IL-2 requirement as indicated by an increase of the G1/S ratio (see bottom of each panel in Figure 7 ). As expected, a parallel upregulation of p27
Kip1 was also observed in all cell lysates following drug treatment and G1 arrest.
These results demonstrate that the inability of HTLV-I-transformed T-cells to arrest in G1 following antiproliferative signals is due to an event that occurs upstream of the cyclin E/CDK2 complex and that limiting amount of p27
Kip1 protein may be maintained by the constitutive activation of P13K, since LY294002 treatment of HTLV-I-transformed cells resulted in p27
Kip1 upregulation and G1 arrest.
Discussion
The progression of HTLV-I-infected T-cells from an immortalized to a transformed state is characterized by acquisition of independence from exogenous growth factors (transformation). To investigate the biochemical basis underlying this transition, we studied the response of HTLV-I-immortalized (N1186) and -transformed (N1186-94) sibling T-cell lines to antiproliferative signals such as serum starvation, rapamycin treatment, and exposure to a PI3K speci®c inhibitor with the aim to understand whether alteration of cell-cycle inhibitors may account for the deregulated growth of HTLV-I-infected cells. Our studies indicate that in HTLV-I transformation the constitutive activation of the cyclin E-CDK2 catalytic activity is determined by the limiting amount of p27 Kip1 , maintained low probably by the constitutive activation of PI3K activity. IL-2 modulates the expression of the cell-cycle regulatory proteins, p21
Waf1 and p27 Kip1 , in proliferating T-cells Nourse et al., 1994) . p21
Kip1
, at the appropriate stoichiometry, inhibit cyclin E-CDK2 activity, which, in turn, controls the transition of cells through the R point into the S phase. Analysis of the cyclin E-CDK2 complex and its catalytic activity after growth-factor deprivation revealed a downregulation of kinase activity in HTLV-I-infected IL-2-dependent T-cell lines. This event correlated with an increase in inactive CDK2, a concomitant upregulation of p27 Kip1 , and G1 arrest. In contrast, in HTLV-I-transformed (IL-2-independent) T-cells, though increasing amounts of inactive CDK2 were detectable, the amount of p27 Kip1 assembled in the cyclin E-CDK2 complex appeared limiting and cells failed to arrest in G1. Because p27 Kip1 inhibits cyclin-CDK complexes by interfering with CDKs phosphorylation , the lack of induction of this inhibitor in transformed cells could result in the continuous phosphorylation of CDK2 and the constitutive activation of the cyclin E-CDK2 complex. This hypothesis is further substantiated by the quenching of cyclin E-associated kinase activity observed when lysates containing high levels of p27 , as also suggested by the ®nding that the amount of p27
Kip1 is lower in transformed than immortalized T-cells. It has been shown that IL-2 decreases the stability of p27
Kip1 by increasing its proteolysis (Pagano et al., 1995) ; this event is presumably mediated by PI3K phosphorylation activity (Brennan et al., 1997) .
The constitutive activation of the IL-2 pathway in most of the IL-2-independent T-cell lines may be a key determinant in maintaining low levels of p27 Kip1 through PI3K. However, it should be noted that p27
Kip1 is expressed at very low levels also in the C91/ PL and C-8166 cell lines (Figure 7) , in which the IL-2R pathway is not constitutive (Mulloy et al., 1998) , and that those cells nevertheless arrested in G1 upon LY294002 treatment. Thus, signaling pathways other than the JAK/STATs may be involved in promoting the growth of a minority of HTLV-I-infected T-cell lines.
Although at this stage it is not possible to rule out the possibility that viral genes may be responsible for low protein levels of p27
, it is unlikely that, as in the case of p21
Waf1 (Cereseto et al., 1996) , Tax, the viral transcriptional transactivator, could be involved. p27
Kip1 mRNA levels do not dier in HTLV-I-infected dependent or independent cells, and modulation of the expression of other HTLV-I accessory genes does not correlate with the IL-2-dependent/independent status of the HTLV-I-infected T-cells .
The importance of p27 Kip1 in the regulation of T-cell proliferation Nourse et al., 1994) has also been con®rmed by studies on p27
-null mice (Fero et al., 1996; Kiyokawa et al., 1996; Nakayama et al., 1996) . These animals were presented with increased proliferation of thymocytes, resulting in thymic hyperplasia and an increased responsiveness of splenic and thymic T-cells to IL-2, which, in turn, correlated with higher cyclin E-associated kinase activity.
Similar to other growth factors, IL-2 upregulates p21
Waf1 and its expression remains elevated in proliferating T-cells. We, as well as others, have previously shown that p21
Waf1 expression is increased in HTLV-Iinfected T-cells and that Tax can induce its expression in a p53-independent manner (Akagi et al., 1996; Cereseto et al., 1996) . Increasing amounts of p21 Waf1 correlated with constitutive activation of the cyclin E complex, suggesting that, at a particular stoichiometry, p21
Waf1 may lower the activation threshold of the cyclin E-CDK2 complex (La Baer et al., 1997; Macleod et al., 1995; Zhang et al., 1994) .
Aberrant expression of cyclin E is found in several types of tumors and some leukemias (Gong et al., 1994; Keyomarsi et al., 1994; Keyomarsi and Pardee, 1993; Leach et al., 1993) . Although the level of expression of this cyclin appears to be normal in HTLV-I-infected cells (Figure 3 ), its associated catalytic activity is constitutive in the late phase of HTLV-I transformation and this correlates with a lack of response to antiproliferative signals. The constitutive activation of the cyclin E-CDK2 complex is probably determined by insucient amount of the cell-cycle inhibitor p27
Kip1 assembled to the complex and possibly by the presence of high levels of p21
Waf1
, both IL-2-regulated proteins. Therefore, the progression of HTLV-I immortalized (IL-2-dependent) T-cells to a transformed phenotype (IL-2 independent), which in most cases correlates with the constitutive activation of the JAK/STAT pathway (Migone et al., 1995; Takemoto et al., 1997; Xu et al., 1995) , is associated with the maintenance of low levels of p27 Kip1 , an event regulated by the PI3K activity. This, in turn, determines the constitutive activation of the cyclin E-CDK2 catalytic activity. A complete understanding of the mechanisms that regulate PI3K and p27
Kip1 will lead to a better understanding of HTLV-I oncogenesis in vitro and hopefully in vivo.
Materials and methods
Cell culture and treatments
Peripheral blood mononuclear cells (PBMCs) from healthy blood donors were separated by Ficoll gradient and stimulated with 10 mg/ml PHA (phytohemagglutinin) (Boehringer-Mannheim, Indianapolis, IN, USA) and 20 units/ml of IL-2 (Boehringer-Mannheim). PBMCs and the HTLV-I-infected T-cell lines, N1186 and N1186-94, were grown in RPMI 1640 containing heat-inactivated fetal bovine serum (10 ± 20%), L-glutamine (0.3 ng/ml), penicillin (100 U/ml), and streptomycin (100 U/ml). Recombinant human IL-2 (20 U/ml) was added to the growth medium of N1186 (Migone et al., 1995) cells and to PBMCs. For the starvation experiments, PBMCs, N1186, and N1186-94 (Migone et al., 1995) and N1185, LAF, C10/MJ, MJ, C91/ PL, MT-2, and C8166 (Cereseto et al., 1996) were grown for three days in media containing 0.1% of serum with no IL-2. When indicated, rapamycin (60 nM) (Calbiochem, La Jolla, CA, USA) or LY294002 (40 mM for 24 h) (Calbiochem) dissolved in DMSO was added to the culture media and equal volumes of DMSO were added to mock cultures.
Cell-cycle analysis
5610
5 cells were washed twice in PBS. Cells were then ®xed in 1 ml of 75% ethanol and incubated on ice for 30 min. The cells were then washed twice in PBS and treated with 3.5 mg of DNAse-free RNAse (BoehringerMannheim) for 30 min at 378C. Finally, cells were pelleted and resuspended in 0.5 ml of propidium iodide (50 mg/ml) (Sigma Chemical Co., St Louis, MO, USA). DNA pro®les were analysed with a Becton Dickinson FACScan (Mountain View, CA, USA) using the CellFit software.
Antibodies
Monoclonal antibodies to cyclin E were purchased from Pharmingen (San Diego, CA, USA), and monoclonal antibodies to p27
Kip1 and p21 Waf1 were purchased from Transduction Laboratories (Lexington, KY, USA) and Oncogene Science (Cambridge, MA, USA).
Immunoblot analysis
Cell extracts were prepared as described (Cereseto et al., 1996) and protein concentrations were determined using the Bradford assay (Bio-Rad, Hercules, CA, USA). For immunoprecipitations, 900 mg of protein lysate was incubated with speci®c antibodies; the immunocomplexes were collected using 20 ml of protein G-Sepharose (Boehringer-Mannheim) and washed three times in lysis buer. As negative controls for cyclin E antibody, the same amounts of protein lysate were treated with mouse serum and protein G-Sepharose. The immunoprecipitates and the protein lysate for Western blots (30 mg) were resolved on 14% SDS ± PAGE gels transferred to nitrocellulose membranes and incubated with monoclonal antibodies. Chemiluminescent detection of blotted proteins was performed using the ECL kit (Amersham, Arlington Heights, IL, USA).
Cyclin E-kinase assay
Cells were lysed with the same lysis buer used for the immunoblot analyses. Protein lysates (200 mg) were incubated with monoclonal antibody against cyclin E. Immunocomplexes were collected using 20 ml of protein GSepharose and washed three times with lysis buer and twice in kinase buer (50 mM HEPES pH 7.5, 10 mM MgCl 2 , 5 mM MnCl 2 , 1 mM DTT). Histone H1-kinase assays were performed by adding 30 ml of kinase buer containing 10 mM ATP, 16 mCi [a-32 P]ATP (DuPont NEN, Boston, MA, USA), and 1.6 mg histone H1 (Boehringer Mannheim), followed by incubation at 378C for 30 min. The reaction was terminated by the addition of 30 ml of SDS ± PAGE loading buer and heated at 1008C for 5 min. Samples were run on 14% SDS ± PAGE gels and analysed by autoradiography. The relative intensity of the bands was quantitated by Phosphorimager analysis (Molecular Dynamics, Sunnyvale, CA, USA). Extracts of N1186-94 cells and PHA-PBMCs were obtained after treatment of the cells as described above for the starvation experiments. Brie¯y, 200 mg of protein lysates of G1-arrested PHAPBMCs were added to 100 mg of protein lysate derived from starved N1186-94 cells in a ®nal volume of 100 ml and incubated for 1 h at 378C. 400 ml of lysis buer was added before proceeding with the immunoprecipitation using antibodies against cyclin E and followed by the histone H1-kinase assay. For some experiments, PHA-PBMCs lysates were treated with three rounds of monoclonal antibodies against p27 Kip1 and protein G-Sepharose (Boehringer Mannheim) to deplete p27
Kip1 or with control serum. When indicated, PHA-PBMCs lysates were heated at 1008C for 5 min and centrifuged in a microfuge at top speed for 5 min before addition to N1186-94 lysates.
